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We report that deoxycholate (DOC), a hydrophobic bile acid associated with a high-fat diet, activates the autophagic pathway in
non-cancer colon epithelial cells (NCM-460), and that this activation contributes to cell survival. The DOC-induced increase in
autophagy was documented by an increase in autophagic vacuoles (detected using transmission electron microscopy, increased
levels of LC3-I and LC3-II (western blotting), an increase in acidic vesicles (ﬂuorescence spectroscopy of monodansycadaverine
and lysotracker red probes), and increased expression of the autophagic protein, beclin-1 (immunohistochemistry/western
blotting). The DOC-induced increase in beclin-1 expression was ROS-dependent. Rapamycin (activator of autophagy) pre-
treatment of NCM-460 cells signiﬁcantly (P<. 05) decreased, and 3-MA (inhibitor of autophagy) signiﬁcantly (P<. 05)
increased the cell loss caused by DOC treatment, alone. Rapamycin pre-treatment of the apoptosis-resistant colon cancer cell
line, HCT-116RC (developed in our laboratory), resulted in a signiﬁcant decrease in DOC-induced cell death. Baﬁlomycin A1
and hydroxychloroquine (inhibitors of the autophagic process) increased the DOC-induced percentage of apoptotic cells in HCT-
116RC cells. It was concluded that the activation of autophagy by DOC has important implications for colon carcinogenesis and
for the treatment of colon cancer in conjunction with commonly used chemotherapeutic agents.
Copyright © 2009 Claire M. Payne et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Colon cancer is the second leading cause of cancer deaths
among men and women combined in the United States,
Australia, and Europe and is a major problem in many
other countries. Approximately 50% of colorectalcancers are
attributed to dietary factors [1]. A typical Western diet, high
in fat and low in ﬁber, has been shown to contribute to the
development of colon cancer in epidemiologic and animal
studies [2]. Bile acids/salts, present in high concentration
in the feces of patients on a high fat/low ﬁber diet [3],
have been associated with colon cancer risk [4]. The most
common bile acid present in the human feces is deoxycholic
acid (DOC) [5], a hydrophobic bile acid. DOC is a promoter
of colon cancer [2], and also a genotoxic carcinogen [6–8],
and may be responsible for initiating gastrointestinal cancers
(reviewed by Bernstein et al. [9]). However, the mechanism
by which hydrophobic bile acids act in progression to colon
cancer is unclear.
Hydrophobicbileacidsareknowninducersofatleastﬁve
stress-response pathways in gastrointestinal cells, including
ER stress [10], oxidative stress [6, 11–13], nitrosative stress
[14, 15], mitochondrial stress [10–13, 16], and DNA damage
[6, 17–19]. Some of these bile acid-induced cellular stresses
may ultimately lead to cell death by mechanisms that include
both apoptosis [20, 21] and necrosis [16]. Hydrophobic bile2 Journal of Toxicology
acids also promote colon cancer. In addition, they may act
as carcinogens [6, 7] and/or select for outgrowth of clones of
mutant cells resistant to bile acid-induced cell death. One of
the cell survival pathways activated in response to bile acid
exposure is the NF-κB stress-response pathway [11, 20, 22,
23]. Persistent activation of NF-κB causes cells to become
apoptosis-resistant, and such cells tend to acquire mutations,
some of which may contribute to colon cancer.
Another important cell survival pathway is autophagy.
Autophagy (Greek for “the eating of oneself”) is an
evolutionarily conserved lysosomal pathway that allows
eukaryotic cells (yeast to mammals) to survive under
nutrient starvation conditions [24–26]. Macroautophagy
(herein referred to as autophagy) involves the bulk lysosomal
turnover of long-lived proteins, protein aggregates, and
organelles such as damaged mitochondria [27], damaged
endoplasmic reticulum (ER) [28], and ribosomes [29]. The
autophagic process occurs in several stages that begin with
the formation of a crescent-shaped isolation membrane
(phagophore) that sequesters organelles, matures into an
autophagosome that surrounds the organelle, followed by
the fusion of the autophagosome with a lysosome to form
an autophagolysosome [30, 31]. Hydrolytic enzymes within
the acid pH of the interior of the autophagolysosome, then
act to degrade macromolecules, thereby providing nutrients
for the survival of the eukaryotic cell [26]. An analysis of
this morphologic process at the molecular level reveals a
complex series of biochemical events involving the products
of numerous autophagy-related genes [24, 26, 32–35]. The
autophagy pathway is becoming increasingly recognized as
an important mechanism of tumor cell survival and drug
resistance in cancer chemotherapy [36–38] .Ar e c e n ts t u d y
indicatedthatautophagyisactivatedincolorectalcancercells
and contributes to tolerance to nutrient deprivation [39].
We now show, for the ﬁrst time, that deoxycholate (DOC)
activates the autophagic pathway in noncancer colon epithe-
lial cells (NCM-460), and that this activation contributes to
cell survival. We also show that the constitutive activation of
autophagy contributes to the survival of apoptosis-resistant
colon cancer cells (HCT-116RC) that were developed in our
laboratorybyrepeatedexposuretoincreasingconcentrations
of DOC [40].
The present ﬁndings, coupled with ﬁndings from our
in vivo animal model of deoxycholate-induced colonic
inﬂammation [17] and from our in vitro apoptosis-resistant
colon cancer cell lines [40], implicate autophagy in colon
carcinogenesis and suggest an additional mechanism by
which hydrophobic bile acids contribute to colon car-
cinogenesis. These studies may aid in the identiﬁcation
of potential biomarkers of the autophagy pathway in the
nonneoplastic colonic mucosa of patients at risk for colon
cancer. In addition, combining inhibitors of autophagy with
chemotherapeutic agents commonly used to treat colon
cancer may lead to an improved clinical outcome.
2.MaterialsandMethods
2.1. Chemicals. Sodium deoxycholate (DOC), 3-methyla-
denine (3-MA), rapamycin (Rapa) (derived from Strep-
tomyces hygroscopicus), CuDIPS [copper(II) 3,5-diiso-
propylsalicylate hydrate), and catalase (10000–40000U/mg
protein) were obtained from Sigma-Aldrich (St. Louis,
Mo, USA). Baﬁlomycin A1, MnTBAP [Mn (III) tetrakis
(4-benzoic acid) porphyrin chloride], HBED [N,N
 -Di-(2-
hydroxybenzyl)ethylenediamine-N,N
 -diacetic acid)], pep-
statin A, and E-64d were from BIOMOL Research Labo-
ratories (Plymouth Meeting, Pa, USA), hydroxychloroquine
sulfate (HCS) was from Acros Organics (Morris Plains, NJ),
and trypan blue was from Gibco BRL Life Technologies
(Grand Island, NY, USA). The concentrations used to
modulate autophagy and cell death in the cell culture
experiments are provided below. In all instances, the speciﬁc
concentrations that were reported in the literature were
tested for their eﬀect on the viability of NCM-460 and HCT-
116RC cells used in the present study. In some instances
dose-response curves that assess the concentration of the
drug and its eﬀect on cell viability were performed to ensure
that the concentration of the chemical itself was not too
toxic to be used in the proposed experiments. This was
especially important for 3-MA, which is used at a wide
range of millimolar concentrations in published reports.
The three antioxidants (HBED, MnTBAP, CuDIPS) used to
evaluate the DOC-induced increase in beclin-1 expression
were used at the same concentration (100μM) so that direct
comparisons can be made. The concentration chosen was
well within the range of concentrations reported in the
literatureforusewithculturedcells(seecitedarticlesbelow),
and this concentration did not induce any cytotoxicity in the
sensitive NCM-460 cells. CuDIPS: 100μM[ 15]; Baﬁlomycin
A1:1 n M[ 41, 42]; Catalase: 1000U/mg; E-64d: 10μg/mL
[43]; 3-MA: 4mM; HBED: 100μM[ 44, 45]; HCS: 10μM
[46]; MnTBAP: 100μM[ 47]; Pepstatin A: 10μg/mL [43];
Rapa: 100μM.
2.2. Cell Lines and Tissue Culture Conditions. The NCM-
460 colon cell line was obtained from INCELL Corporation,
LLC (San Antonio, Tex, USA) and cultured in M3:10TM
medium to insure that it maintains its characteristic features.
This cell line was not obtained from a colon cancer and is
considered to be a noncancerous colonic epithelial cell line.
HCT-116RC is a stable apoptosis-resistant colon cancer cell
line that was developed in our laboratory after persistent
exposure to increasing concentrations of NaDOC [40]. This
cell line was maintained in DMEM media supplemented
with 10% heat-inactivated fetal calf serum (Omega Scien-
tiﬁc, Tarzana, Calif, USA), 1% MEM nonessential amino
acids, 100μg/mL streptomycin, 100U/mL penicillin, and
3.44mg/mL L-glutamine. Media components were from
Gibco BRL Life Technologies (Grand Island, NY, USA). All
treatments utilizing NCM-460 cells were performed with
the cells in approximate mid-logarithmic phase to avoid
inconsistencies in cellular responses based on growth phase,
as previously described [48]. Starvation experiments were
performed by incubation cells in Hank’s Balanced Salt
Solution (HBSS), as previously described for colon epithelial
cells [49]. HBSS was obtained from Gibco/Invitrogen Corp.,
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2.3. Assessment of Vacuolar Acidiﬁcation. NCM460 cells were
plated on a ﬁbronectin-coated Costar (Fisher Scientiﬁc,
Pittsburg, Pa, USA) 96 well black plate at 2 × 105 cells/mL.
C e l l sw e r et r e a t e dw i t h0 . 4m MD O Cf o r3 0m i n u t e sa n d1
hour. After treatments, cells were spun in an Allegra 6R Cen-
trifuge(BeckmanCoulter,Fullerton,Calif,USA)at1000rpm
for 5 minutes and the ﬂuorescent dyes added as described
below. Triplicate wells were plated for each experimental
protocol, and the intensity values were normalized for each
wellusinganucleicacidstain.Meanfoldchangesinintensity
values (DOC versus control untreated cells) were statistically
compared using Student’s t-test.
2.3.1. Monodansylcadaverine (MDC). MDC (Fluka-Sigma-
Aldrich, St. Louis, Mo, USA) was used at a ﬁnal concen-
tration of 200μM, and cells were incubated for 30 minutes
at 37◦C .M D Cw a sr e m o v e da n dS y t o xG r e e n( M o l e c u l a r
Probes/Invitrogen, Carlsbad, Calif, USA) was added at a ﬁnal
concentration of 2.5μM; cells were incubated for 20 minutes
atroomtemperature.Fluorescencewasassessedimmediately
using an Optima FLUOstar plate Reader (BMG Labtech,
Durham, NC, USA). MDC (excitation 335nm; emission
508nm) and Sytox Green (excitation 504nm; emission
523nm) ﬂuorescence were assessed using appropriate ﬁlters.
All ﬂuorescence values were normalized to the amount of
cells in individual wells by obtaining the ratio of MDC
ﬂuorescence (assessment of acid vesicles) to Sytox Green
ﬂuorescence (nucleic acid stain).
2.3.2. LysoTracker Red. LysoTracker Red (Molecular Probes/
Invitrogen, Carlsbad, Calif, USA) was added to the cells at a
ﬁnal concentration of 100nM and incubated for 30 minutes
at 37◦C. Lysotracker Red was removed and Hoechst # 33342
dye (Molecular Probes/Invitrogen, Carlsbad, Calif, USA),
made up in tissue culture media at a ﬁnal concentration
of 10μg/mL, was added to the cells and incubated for
10 minutes at 37◦C. Cells were spun at 1000rpm for 10
minutes, the supernatant removed, and the pelleted cells
were ﬁxed with 4% formaldehyde in PBS for 20 minutes at
room temperature. Fluorescence at 30 minutes and 1 hour
was assessed immediately using an Optima FLUOstar plate
Reader (BMG Labtech, Durham, NC, USA). LysoTracker
Red (excitation 577nm; emission 590nm) and Hoechst
(excitation 350nm; emission 461nm) ﬂuorescence were
assessed using appropriate ﬁlters. All ﬂuorescence values
were normalized to the amount of cells in individual wells
by obtaining the ratio of LysoTracker Red ﬂuorescence
(assessmentofacidvesicles)toHoechstﬂuorescence(nucleic
acid stain).
2.4. Western Blot Analysis. Cells were grown in 20 ×
100mm Falcon polystyrene tissue culture dishes (Fisher
Scientiﬁc, Pittsburgh, Pa, USA). Cultures treated with DOC
or incubated in control media were disrupted in lysis buﬀer
( 5 0m MT r i sp H8 ,5m ME D T A ,1 5 0m MN a C l ,0 . 5 %N P -
40) supplemented with 1mM phenylmethylsulfonyl ﬂuoride
(PMSF), leupeptin (1μg/mL), and aprotinin (0.01U/mL).
Cell lysates were prepared at a concentration of 2μg/μL
of protein, and 10μg of protein were added to each well
of a 15% Criterion Tris-HCl gel (Biorad, Hercules, Calif,
USA) for size fractionation by electrophoresis. The proteins
were blotted onto Immobilon-P PVDF transfer membrane
(Millipore, Bedford, Mass, USA). The membranes were
incubated with a mouse antibeclin monoclonal antibody
(BD Transduction Laboratories, San Diego, Calif, USA) at
a dilution of 1 : 1000 or rabbit anti-LC3B polyclonal
antibody (Cell Signaling Technology, Inc., Boston, Mass,
USA) at a dilution of 1 : 500. The membranes were then
incubated with goat antimouse or goat antirabbit secondary
antibodies conjugated to horseradish peroxidase (Pierce,
R ockfor d,Ill,USA).Antibodyc omplex eswer edetectedusing
the SuperSignal West Pico chemiluminescence detection
system (Pierce, Rockford, Ill, USA). Finally, the membranes
were stained for 20 minutes with Brilliant Blue G dye
(Sigma-Aldrich, St. Louis, Mo, USA) to conﬁrm equal
protein loading. We have chosen to use the staining of
the membranes with Brilliant Blue G dye rather than a
speciﬁc protein as a loading control, since the former looks
at numerous bands, whereas the latter can be misleading.
This is based on work published from our laboratory using
GAPDH and G3PD [50], and those of others who screened
22 housekeeping genes [51] and found a large number to be
modulated by various experimental conditions.
All western blot experiments were repeated at least three
times; in the repeats, separate cultures were treated, and
cell lysates were separately prepared. The band intensities
after DOC treatments or starvation conditions (incubation
in HBSS) were then statistically compared using automated
densitometry (QuantiScan Imaging Analysis, Biology Soft-
ware Net, UK) and the values normalized to the control
values. Two replicates from the same lysate were also run to
ensure technical reproducibility.
2.5. Immunohistochemistry Procedures. Cells were grown in
20 ×100mmFalconpolystyrenetissueculturedishes.NCM-
460 cells were treated with 0.2mM DOC for 24 hours.
Control (untreated) and DOC-treated cells were trypsinized,
washedwithPBSandﬁxedwith4%formaldehydeovernight.
Cell pellets were paraﬃn-embedded, and 4 micron sections
were prepared. The details of the immunohistochemical
procedures have been previously described [52]. Brieﬂy,
after deparaﬃnization, rehydration, and incubation in 3%
hydrogen peroxide in methanol, sections were blocked with
1.5% goat serum (Vector Laboratories, Burlingame) and
immunostained using a polyclonal antibeclin-1 antibody
from ProSci Inc. (Poway, Calif, USA) at a concentration of
1μg/mL. Sections were then incubated using a biotinylated
antirabbit secondary antibody (Vector Laboratories), Vec-
tastain Elite ABC (Avidin Biotin Complex) reagent (Vector
Laboratories), and DAB (3-3 diaminobenzidine) activated
by hydrogen peroxide. Sections were then counterstained
with hematoxylin.
2.6. Cytotoxicity Assays
2.6.1.TrypanBlueExclusionAssay. NCM-460andapoptosis-
resistant HCT-116RC cells were plated at 2 × 105 cells/mL4 Journal of Toxicology
in a 24 well Falcon plate. After treatments, the super-
natantscontainingﬂoaterswereremoved,adherentcellswere
trypsinized and added to the ﬂoaters. An equal volume
of trypan blue solution was added to a 50μLa l i q u o to f
the supernatant containing adherent cells and ﬂoaters. A
minimum of 100 cells were counted on a hemacytometer
slide under the 10X objective of a brightﬁeld microscope.
The percentage of cells that were stained with trypan blue
was determined for each treatment. Each experiment was
performed at least twice.
2.6.2.QuantitationofApoptosisandNecrosis. Cellswerespun
onto Glass slides using the Cytospin 3 (Shandon, Pittsburg,
Pa, USA) and then were ﬁxed in 100% methanol for 3
minutes. To stain the slides, 10% Giemsa stain (Sigma) were
added for 4 hours. Cells were examined under a 100 X oil
immersion lens and evaluated for apoptosis and necrosis,
using criteria previously reported for brightﬁeld microscopy
[21]. All cell death experiments were repeated at least twice
with similar results. To evaluate statistical signiﬁcance, 100
c e l l sw e r es c o r e df r o m5d i ﬀerent areas of the slide, and a
mean ± S.D. was obtained for each experimental group. The
diﬀerence between groups was considered signiﬁcant at the
95% probability level using Student’s t-test.
2.7. Transmission Electron Microscopy (TEM). Cells were
grown in 10 × 35mm Falcon polystyrene tissue culture
dishes (Fisher Scientiﬁc, Pittsburgh, Pa, USA). All cells
were pretreated with protease inhibitors (10μg/mL E-64d,
10μg/mL pepstatin A) to enhance the identiﬁcation of
cellular organelles and debris in autophagic vacuoles. Cells
were then incubated with 0.4mM DOC for 1–3 hours.
Control cells were incubated in the absence of DOC for
the same period of time. A total of at least 3 × 106 cells
from the two kinds of treatment groups were rinsed in PBS
and ﬁxed in situ with 1% glutaraldehyde made up in 0.1M
cacodylate buﬀer (pH 7.2) for 30 minutes. Cells were then
scraped from the surface of the tissue culture plates using
a rubber policeman, pelleted, and then resuspended in 3%
glutaraldehyde made up in 0.1M cacodylate buﬀer (pH 7.2)
for 2 hours at 4◦C. Cells were washed in PBS, postﬁxed
in 2% osmium tetroxide, dehydrated in a graded series of
ethanols, and embedded in Spurr’s epoxy resin. Ultrathin
sections were stained with uranyl acetate and lead citrate and
photographed using a Philips CM12S transmission electron
microscope operating at 80keV.
3. Results
3.1. DOC Activates the Autophagic Pathway in Noncancer
Colonic Epithelial Cells (NCM-460). Since NCM-460 cells
are very sensitive to DOC-induced cytotoxicity, only 1–
3 hour experiments were performed using 0.4mM DOC;
longer treatment times with this concentration of DOC
resulted in signiﬁcant apoptosis and necrosis. Treatment of
NCM-460 cells with 0.4mM DOC for 1–3 hours resulted in
the appearance of autophagic vacuoles, assessed using TEM
(Figure 1). These ultrastructural ﬁndings are considered
(a) (b)
(c)
M
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Figure 1: Transmission electron micrographs of control NCM-
460 colonic epithelial cells (a) and cells treated with 0.4mM
DOC for 1 (b), 2 (c), and 3 (d) hours. Note the increase in
number and size of autophagolysosomes after DOC treatment. (a)
Arrow indicates the presence of small, electron-dense lysosomes;
X4,400); (b) arrow indicates a large autophagolysosome with
adjacent smaller autophagolysosomes in the process of fusing with
the larger autophagolysosome (X7,100); (c) a large number of
autophagic vacuoles containing cellular debris in various stages of
degradation are present (X7,100); (d) arrow indicates the presence
of a mitochondrion (M) within an autophagic vacuole (X15,000).
(All cells were pretreated with protease inhibitors to retard the
degradation process within lysosomes (see Section 2); this allowed
the identiﬁcation of cellular organelles that were diﬃcult to observe
in the absence of the protease inhibitors.) (Uranyl acetate, lead
citrate counterstains.)
one of the gold standards for identifying the activation of
autophagy [53]. Another major ﬁnding was the increase
in expression of microtubule-associated proteinlight chain
3 (LC3), the mammalian homologue of the yeast Atg8
autophagic protein [54]. The appearance of cytosolic LC3-
I by posttranslational modiﬁcation of Pro-LC3 by hATG4B
[55] and the dynamic increase in the formation of LC3-
II (a LC3-phospholipid conjugate) and localization to
autophagosomal membranes [55] over time in the presence
of protease inhibitors (E-64d and pepstatin A) are consid-
ered another excellent indication for the activation of the
autophagic pathway [44]. The use of protease inhibitors
prevents the degradation of LC3-II which is membrane-
bound and subject to proteolytic degradation in mature
autophagolysosomes. We preincubated NCM-460 cells in
media containing 10μg/mL E-64d and 10μg/mL pepstatin A
for 24 hours and then exposed cells to 0.4mM DOC for 0-1
hour, a time period that we determined to have abundant
autophagic vacuoles by TEM and prior to the appearanceJournal of Toxicology 5
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Figure 2: Western blot analysis of LC3-I and LC3-II protein expressions in NCM-460 cells in the presence of protease inhibitors (see
Section 2) under normal conditions, after DOC treatment (a), (c), (d), and under starvation conditions (e), (g), (h). Bar graphs compare the
protein expression of LC3-I and LC3-II over time using computerized densitometric analysis (c), (d), (g), (h). (a), (c), (d) represent LC3-I
and LC3-II protein expressions after incubation with 0.4mM DOC for 30 and 60 minutes compared to control cells that were not incubated
with DOC.(e), (g),(h) represent LC3-Iand LC3-II protein expressions at the same time points under starvation conditions usingHBSS. The
membranes were stained with Brilliant Blue G dye to conﬁrm equal protein loading (Figures 2(b), 2(f)). (∗ indicates statistically signiﬁcant
(P < .05) diﬀerences in mean Relative Densitometric Units (RDU) between treatment and untreated control groups.)
of apoptotic or necrotic cells. Figure 2 shows Western blots
and densitometric analysis of DOC-treated NCM-460 cells
(Figures 2(a)–2(d)) and starved cells (incubation in HBSS)
as a positive control (Figures 2(e)–2(h)), indicating the
dynamics associated with the appearance of LC3-I and LC-3-
II. It can be seen that both LC3-I and LC3-II were increased
by DOC and starvation conditions at the 1 hour time
point compared to control untreated cells, indicating the
activation of the early cytosolic form of LC3 (LC3-I) and
the late membrane-bound form of LC3 (LC3-II). In diﬀerent
experiments the basal level of LC3-I was more variable than
that of LC3-II. The reason for this is not clear, but may
relate to diﬀerent number of cell passages. In all cases, the
basal levels of both LC3-I and LC3-II were increased by both
DOC and starvation conditions; however, the actual fold
increasecannotbedirectlycomparedbecauseofthisinherent
variability.
As shown in Figures 2(e)–2(h), the increase of LC3-I and
LC3-II over time in the presence of the protease inhibitors
was observed under starvation conditions as was observed
after incubation in 0.4mM DOC (Figures 2(a)–2(d)). This
increase in LC3-I and LC3-II levels after DOC treatment was
similar to the ﬁndings of Ellington et al. [56] who studied
soybean B-group triterpenoid saponin-induced autophagy
in a colonic adenocarcinoma cell line (HCT-15). In the
present study and that of Ellington et al. [56], this increase6 Journal of Toxicology
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Figure 3: Eﬀect of 0.4mM DOC on the acidiﬁcation of vesicles
using MDC and Lysotracker Red (LTR) ﬂuorescence assessed with
a microplate reader. Note the statistically signiﬁcant increase in
vesicular acidiﬁcation within 30 (LTR)–60 (MDC) minutes after
DOC treatment. (∗ indicates statistically signiﬁcant (P < .05)
diﬀerences in mean Relative Fluorescence Units (RFU) between
treatment groups and untreated control groups.)
in expression of LC3-I and LC3-II was accompanied by the
presence of autophagic vacuoles assessed by TEM, the classic
gold standard for the activation of the autophagic pathway.
Anearlystepintheautophagicprocessistheacidiﬁcation
of cytoplasmic vesicles, which provides the acidic milieu
necessary for the optimal activity of digestive enzymes con-
tained within lysosomes. We were able to demonstrate the
acidiﬁcation of vesicles within 30 to 60 minutes after DOC
treatment by assessing either the increase in ﬂuorescence of
MDCo rL y sotrac k e rR ed(Figure 3),twodyesthattargetacid
vesicles [57, 58]. The TEM studies coupled with the LC3
results and the vesicular acidiﬁcation assays strongly indicate
thathydrophobicbileacidscanactivateautophagyasanearly
stress-response pathway.
DOC also induced an increase in beclin-1, an essen-
tial autophagy protein [59]. NCM-460 cells were exposed
to 0.2mM DOC for 24 hours, and beclin-1 expression
was assessed using immunohistochemical (Figure 4(a))a n d
Western blot (Figures 4(b)–4(d)) analysis. This concen-
tration of DOC did not induce appreciable apoptosis
during a 24-hour period and was, therefore, chosen for
this experiment. Treatment with 0.2mM DOC induced a
dramatic increase in the protein levels of beclin-1 using both
techniques.
3.2. DOC-Induced Increase in Beclin-1 Expression Is Mediated
through an Oxidative Stress Mechanism. Since DOC induces
a signiﬁcant amount of oxidative/nitrosative stress [6, 11–
15], we determined if the DOC-induced increase in beclin-
1 expression was mediated, in part, through an oxidative
mechanism. We pretreated NCM-460 cells for 2 hours with
4d i ﬀerent agents that reduce oxygen-free radicals through
diﬀerent mechanisms, followed by a 24-hour incubation
with 0.2mM DOC. The 4 agents used were catalase, HBED,
MnTBAP, and CuDIPS. Catalase catalytically breaks down
hydrogen peroxide to water and oxygen [60]; HBED is an
iron chelator and inhibits ferric ion catalyzed formation of
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Figure 4: Immunohistochemical (a) and Western blot analysis
(b), (c) of beclin-1 protein expression in NCM-460 cells in the
absence and presence of 0.2mM DOC for 24 hours. (a) There
is a dramatic increase in the staining of beclin-1 in both the
nucleusandcytoplasmofDOC-treatedcells(rightpanel)compared
with control untreated cells (left panel). Beclin-1 staining also
occurs in association with the nucleolus where a ring of brown
staining is observed in several cellular proﬁles in DOC-treated cells.
(100X oil objective; brown color of DAB indicates positive beclin-
1 staining; blue color indicates hematoxylin stain). (b) Western
blot indicating the increase in the beclin-1 61kDa band after DOC
treatment. (c) The membranes were stained with Brilliant Blue
G dye to conﬁrm equal protein loading for western blot analysis.
(d) Computerized densitometric evaluation of bands shown in
(b). (∗ indicates statistically signiﬁcant (P < .05) diﬀerences in
mean Relative Densitometric Units (RDU) between treatment and
untreated control groups.)
hydroxyl radicals [45]; MnTBAP is a cell permeable super-
oxide dismutase mimetic (SOD) and peroxynitrite scavenger
[61, 62]; CuDIPS is a cell permeable SOD mimetic [63]. All 4
agents had a marked eﬀect on preventing the DOC-induced
increase in beclin-1 expression, although catalase was the
most eﬀective (Figure 5). In addition, it was determined that
the constitutive levels of beclin-1 are also highly dependent
on endogenous oxidative stress levels in the cell. As shown in
Figure 5, all 4 antioxidants decreased the constitutive levels
of beclin-1, with catalase being the most eﬀective.
3.3. Autophagy Protects NCM-460 Cells from DOC-Induced
Cell Death. To determine whether the activation ofJournal of Toxicology 7
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Figure 5: Eﬀect of antioxidants and an antioxidant enzyme on
protein expression of beclin-1. Cells were pretreated for 2 hours
with either catalase, HBED, MnTBAP, or CuDIPS, followed by
a 24-hour incubation with 0.2mM DOC. (a) All pretreatments
decreased both the constitutive beclin-1 protein levels and the
DOC-induced increase in beclin-1 protein levels, with catalase
being the most eﬀective. (b) The Brilliant Blue loading control with
the position of the beclin-1 band indicated by the arrow.
autophagy contributes to DOC-induced cell death or is
a prosurvival stress-response pathway, NCM-460 cells
were pretreated with rapamycin, an agent that activates
autophagy [64], and 3-methyladenine (3-MA), an agent that
inhibits the autophagic process [65]. NCM-460 cells were
pretreated with 100μM rapamycin (Figure 6(a))o r4 m M
3-MA (Figure 6(b)) for 24 hours and then incubated with
0.4mM DOC for 4 hours. Total cell number and the trypan
b l u ee x c l u s i o na s s a yw e r eu s e da sm e a s u r e so fc e l lg r o w t h
and viability.
DOC treatment, alone, resulted in a signiﬁcant (P < .05)
decrease in cell counts compared to untreated control cells.
Rapamycin pretreatment signiﬁcantly (P < .05) decreased
trypan blue uptake and prevented the cell loss caused by
DOCtreatment(Figure 6(a)).Thesigniﬁcantdecreaseincell
counts in the absence of signiﬁcant trypan blue uptake by
100μM rapamycin, alone (Figure 6(a)), is most probably a
reﬂection of a decrease in cell proliferation caused by the
activationofautophagy.Oppositetotheeﬀectsofrapamycin,
pretreatment with 3-MA signiﬁcantly (P < .05) increased
trypanblueuptakeandincreasedthecelllosscausedbyDOC
(Figure 6(b)).
3.4. Autophagy Protects HCT-116RC Apoptosis-Resistant
Colon Cancer Cells from DOC-Induced Cell Death. We
have previously reported that persistent exposure of HCT-
116 apoptosis-competent colon cancer cells to increasing
concentrations of DOC resulted in the development of
stable apoptosis-resistant cell populations in which several
stress-response pathways were upregulated [40, 66]. It was
determined that the autophagic activity was constitutively
upregulated in each of the apoptosis-resistant cell lines
(HCT-116RB, HCT-116RC, HCT-116RD cells). Increased
autophagy was indicated by the presence of numerous late-
stage autophagolysosomes in the cytoplasm of the resistant
cells, identiﬁed in some cases by the presence of numerous
whorls of digested material [40].
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Figure 6:Bargraphsdemonstratingtheeﬀectsof0.4mMDOCand
100μM rapamycin pretreatment (a) or 0.4mM DOC and 4mM
3-MA (3-methyladenine) pretreatment (b) on cell number and
viability (trypan blue exclusion) of NCM-460 cells. (Signiﬁcant
diﬀerences (P < .05) between treatment groups and control
(untreated) cells are indicated by an asterisk (∗). Signiﬁcant
diﬀerences between DOC treatment, alone, and DOC treatment
after rapamycin or 3-MA pretreatment are indicated by a pound
sign (#).)
To evaluate whether the constitutive upregulation of
the autophagic pathway has a survival function in these
apoptosis-resistant cells or is merely an epiphenomenon, we
exposed HCT-116RC cells to various agents that modulate
the autophagic process. Since the HCT-116RC cells are
resistant to cell death, all experiments requiring bile acid
treatment were performed using 0.5mM DOC, and cells
were treated in late log phase of growth. These conditions
were necessary to elicit a cellular response to autophagy
inhibitors/inducers, as described below. HCT-116RC cells
were pretreated with 100μM rapamycin or 4mM 3-MA
for 24 hours and then incubated with 0.5mM DOC for
an additional 24 hours. Total cell number and the trypan
b l u ee x c l u s i o na s s a yw e r eu s e da sm e a s u r e so fc e l lg r o w t h8 Journal of Toxicology
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Figure 7: Bar graphs demonstrating the eﬀects of 0.5 mM DOC
and 100μM rapamycin pretreatment (a) or 0.5μMD O Ca n d4m M
3-MA (3-methyladenine) pretreatment (b) on cell number and
viability (trypan blue exclusion) of HCT 116RC apoptosis-resistant
cells. (Signiﬁcant diﬀerences (P < .05) between treatment groups
and control (untreated) cells are indicated by an asterisk (∗).
Signiﬁcant diﬀerences between DOC treatment, alone, and DOC
treatment after rapamycin or 3-MA pretreatment are indicated by a
pound sign (#).)
and viability. Similar to the results with the noncancer cell
line, NCM-460, rapamycin pretreatment of the apoptosis-
resistant cancer cell line, HCT-116RC, followed by 24 hours
of treatment with 0.5mM DOC, resulted in a signiﬁcant
(P < .05) increase in cell number and a signiﬁcant (P <
.05) decrease in trypan blue uptake (i.e., increase in viable
cells) compared to DOC treatment, alone (Figure 7(a)).
The signiﬁcant decrease in cell counts in the absence of
signiﬁcant trypan blue uptake by 100μM rapamycin, alone
(Figure 7(a)), is most probably a reﬂection of a decrease
in cell proliferation caused by the activation of autophagy.
On the other hand, pretreatment of HCT-116RC cells with
4mM 3-MA had no eﬀect on increasing cell death induced
by 0.5mM DOC (Figure 7(b)). The signiﬁcant decrease in
cell counts in the absence of signiﬁcant trypan blue uptake
by 4mM 3-MA, alone, is most probably a reﬂection of a
decrease in cell proliferation (Figure 7(b)).
Since we have previously shown that autophagy is
constitutively expressed in these cells [40] and rapamycin
had a signiﬁcant eﬀect on cell survival, the negative results
obtained with the combination of 3-MA and DOC cannot
b et a k e na sc o n c l u s i v ee v i d e n c eo fl a c ko fi n v o l v e m e n to f
autophagy [58]. Since 3-MA inhibits autophagy at an early
stage by preventing the formation of autophagosomes, it
has been reported that in order to adequately assess the
modulation of the autophagy process, inhibitors that act at
ad i ﬀerent stages of the autophagy process should also be
tested [58]. Therefore, HCT-116RC cells were exposed to 2
diﬀerent inhibitors of the autophagic process, baﬁlomycin
A1 and hydroxychloroquine, which act at the level of acid
vesicles/lysosomes [67]. Baﬁlomycin A1 appears to block the
fusion of autophagosomes and lysosomes [68], and hydroxy-
chloroquine (an amine) diﬀuses into acid vesicles/lysosomes
and raises the intraorganellar pH. Baﬁlomycin A1 also raises
the pH of acid vesicles/lysosomes by inhibiting the proton-
translocating ATPase (H+-ATPase) [69]. HCT-116RC cells
were pretreated with 1nM baﬁlomycin A1 for 24 hours
and then incubated with 0.5mM DOC for an additional 24
hours. Baﬁlomycin A1 pretreatment followed by DOC treat-
ment increased the percentage of apoptotic cells 4-fold over
the level of apoptosis induced when DOC was used alone
(Table 1). There was no increase in the percentage of DOC-
inducednecroticcellsbybaﬁlomycinA1 pretreatment.HCT-
116RC cells were pretreated with 10μM hydroxychloroquine
for 24 hours and then incubated with 0.5mM DOC for
an additional 24 hours. Hydroxychloroquine pretreatment
followed by DOC treatment increased the percentage of
apoptotic cells 4-fold over the level of apoptosis induced
by DOC, alone (Table 1(b)). There was no increase in the
percentageof DOC-induced necrotic cells by hydroxychloro-
quine pretreatment.
In summary, the collective data indicate that autophagy
has a survival value for both noncancerous and cancerous
colon cells when exposed to hydrophobic bile acids in a
nutrient-rich environment.
4. Discussion
High concentrations of hydrophobic bile acids, associated
with a high-fat diet, induce proapoptotic and prosurvival
stress-response pathways [13]. The ultimate fate of the cell
depends upon the balance of proapoptotic and antiapoptotic
proteins activated or synthesized in response to bile acid
exposure, and the level of energy demands placed upon the
stressed cell [9]. We hypothesized that persistent cellular
stress induced by bile acids, such as ER stress, DNA damage,
and mitochondrial stress, will lead to the clonal selection of
apoptosis-resistantcellsandtheconstitutiveactivationofcell
survival pathways (Figure 8). We tested this hypothesis by
generating apoptosis-resistant colon cells by repeated expo-
sure of apoptosis-sensitive HCT-116 cells in vitro to increas-
ing concentrations of the hydrophobic bile acid, DOC, andJournal of Toxicology 9
Table 1: (a) Eﬀe c to fb a ﬁ l o m y c i nA 1 on DOC-induced death of
apoptosis-resistant HCT-116RC cells. (b) Eﬀect of hydroxychloro-
quine on DOC-induced death of apoptosis-resistant HCT-116RC
cells.
(a)
Experimental group % apoptotic cells % necrotic cells
(mean ± SEM) (mean ± SEM)
Control (untreated) 2.8 ±1.03 .0 ±0.6
1nMBaﬁlomycinA 1 3.0 ±0.44 .6 ±0.3
0.5 mM DOC 4.2 ±0.92 7 .0 ±3.5
∗
Baﬁlomycin A1 +D O C 1 7 .8 ±3.2
∗# 27.8 ±5.5
∗
(b)
Experimental group % apoptotic cells % necrotic cells
(mean ± SEM) (mean ± SEM)
Control 0.4 ±0.32 .4 ±0.3
∗
10μM Hydroxychloroquine 3.8 ±1.0
∗ 6.4 ±0.6
∗
0.5mM DOC 5.4 ±0.9
∗ 22.4 ±4.3
∗
Hydroxychloroquine + DOC 20.0 ±1.7
∗# 19.8 ±2.6
∗
∗Statistically signiﬁcant (P < .05) diﬀerences in mean values when
compared to untreated control cells; # statistically signiﬁcant (P < .05)
diﬀerencesinmeanvalueswhencomparedtocellstreatedwithDOC,alone,
and this goes for Tables 1(a) and 1(b).
evaluating stress-induced cell death and apoptosis-related
gene expression at the molecular and cellular levels [40, 66].
NF-κB and many proteins that protect against oxidative
stress were constitutively upregulated in these apoptosis-
resistant cells. In addition, the development of apoptosis
resistance was accompanied by the modulation of genes
associated with the autophagy pathway. The autophagy-
relatedgenesthatexhibitincreasedexpressionincludesixrab
genes involved in vesicle transport, a Rab interacting lysoso-
mal protein-like 2 protein (RILPL2), PI(3)K, 2 subunits of
the lysosomal proton (H+)-translocating ATPase, cathepsin
D, lysosomal-associated membrane protein 1 (Lamp-1), a
multipass membrane transporter protein (MFSD8/CLN7),
and prenylcysteine lyase, a lysosomal enzyme involved in
the degradation of prenylated proteins. We also found that
chronic feeding of wild-type B6.129 mice with DOC added
to the diet results in an increase in APG4 [17], a cysteine
protease that acts during the formation of autophagosomes
[70] and whose activity is regulated by reactive oxygen
species (ROS) [71] .T h ef u n c t i o n a lr o l eo fa u t o p h a g yi n
colon carcinogenesis, however, was not determined from
these in vitro microarray and in vivo animal studies.
In the present study, we ﬁrst evaluated the ability of
DOC to activate autophagy in NCM-460 cells, and then
determined whether autophagy has a prosurvival function in
thisnoncancerouscolonepithelialcellline.Wedemonstrated
that DOC activated autophagy using diﬀerent methods of
detection, and that this activation contributed to cell sur-
vival. We next determined that the constitutive upregulation
of autophagy also has a prosurvival function in HCT-
116RC apoptosis-resistant colon cancer epithelial cells. The
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(deoxycholate)
ROS/RNS
ER stress DNA damage Mitochondrial
stress
Pro-survival pathways
(autophagy, NF-κB)
Constitutive up-regulation of
autophagic & anti-apoptotic
proteins
Colon carcinogenesis
NCM-460
cells
HCT-116RC
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Mutations
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Figure 8: Diagram indicating the possible roles of autophagy in
colon carcinogenesis. Hydrophobic bile acids are known to induce
numerous stresses in colon epithelial cells that result in the activa-
tion of prosurvival stress-response pathways. NF-κB activation by
hydrophobic bile acids induces prosurvival pathways. The present
study reports that deoxycholate (DOC), a hydrophobic bile acid
that is important in colon carcinogenesis, activates autophagy.
This activation of autophagy by DOC was also shown to have a
prosurvival function. The constitutive upregulation of prosurvival
pathways (resulting from chronic exposure to DOC and selection
for apoptosis resistance) can enhance mutation rates, which may
lead to the development of colon cancer. NCM-460 and HCT-
116RC cells were used as model cell lines to evaluate the bile acid-
induced activation of the autophagic pathway and its consequences
in the early and late stages of colon carcinogenesis, respectively.
prosurvival mechanism of DOC-induced autophagy is prob-
ably antiapoptotic. This is based on the experiments with
baﬁlomycin A1/hydroxychloroquine, in which we showed
that autophagy prevented cells from undergoing DOC-
induced apoptosis, but not from DOC-induced necrosis.
The possible roles of autophagy in colon carcinogenesis
based on published results and present ﬁndings are shown
schematically in Figure 8. The cellular stresses induced by
hydrophobic bile acids (e.g., ER stress, DNA damage, mito-
chondrial stress) are also inducers of the autophagic pathway
[72–75], most probably mediated through the generation
of ROS [76]. Evidence that DOC induces the autophagic
pathway through an oxidative/nitrosative mechanism was
provided in the present study using 3 diﬀerent antioxidants
in addition to catalase. These antioxidant conditions dra-
matically reduced the level of DOC-induced beclin-1 protein
expression, a major protein involved in the mammalian
autophagic pathway.
The rationale for choosing beclin-1 (homologue of the
yeast autophagy gene apg6/vps30 [77]) to assess the eﬀects of10 Journal of Toxicology
antioxidantsontheDOC-inducedincreaseinautophagywas
basedon (1)its dramatic increase in expression in noncancer
cells by DOC, a known inducer of oxidative stress, compared
to other autophagy-related proteins (data not shown), (2)
its critical involvement in the initial step of autophagosome
formation [78–80], (3) the documented importance of an
increase in beclin-1 at the premetastasis stage of colon
cancer development [81], (4), its role in tumorigenesis, in
general [82, 83], (5) its function as an antiapoptotic protein
[84–87], and (6) its potential as a possible biomarker to
assess colon cancer risk. Although the oxidative mechanism
by which DOC increases beclin-1 protein expression is
most probably multifactorial, we suggest that an important
signaling pathway may involve the generation of ceramide.
This is based on the fact that (1) ceramide is an important
sphingolipid molecule involved in the increase in beclin-1 in
HT-29 colon epithelial cells [88] and other cell types [89],
DOC is known to generate ceramide through several mech-
anisms [80–92], (2) ceramide treatment decreases catalase
enzymatic activity and expression [93], a possible link to the
present ﬁndings indicating that catalase reduces the DOC-
induced increase in beclin-1 expression, and (3) ceramide
can damage mitochondria [94–98], a known inducer of the
autophagic process [99]. Other mechanisms that may be
responsibleforDOC-inducedincreaseinbeclin-1expression
may involve alterations of lipid traﬃcking [100], a process
known to induce beclin-1 expression in other cell types
[101]. Although we focussed on the role of oxidative stress in
the DOC-induced modulation of beclin-1, other aspects of
the autophagic process that are now known to be regulated
by ROS/RNS [102–105] may also be modulated by DOC.
Sincewehaveshownthatautophagyisasurvivalpathway
for apoptosis-resistant colon cancer cells, the constitutive
activation of autophagy and the activation of autophagy
induced by cancer chemotherapeutic agents [106] should,
therefore, be taken into consideration when designing
eﬀective clinical treatment regimens for cancer. We plan to
determine the eﬀectiveness of modulators of autophagy in
combination with cytotoxic drugs, such as 5-ﬂuorouracil,
oxaliplatin, and irenotecan [107, 108], in enhancing cell
death in vitro in our apoptosis-resistant colon cancer cell
lines. The precedence for combining inhibitors of autophagy
with chemotherapeutic agents for the treatment of colon
was recently established [106]. Li et al. [106] reported that
3-MA enhanced the eﬀect of 5-ﬂuorouracil in inducing
apoptosis of colo26 and HT-29 colon cancer cells. It is also
anticipated that a better understanding of the mechanisms of
autophagy in colon cells, their modulation by dietary factors,
and aberrant expression of autophagic proteins during colon
carcinogenesis will contribute to the important ﬁeld of
hypothesis-driven biomarker development to assess colon
cancer risk.
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